The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 140.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 20.00 (14.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Fri, 13th Mar 2020 16:04

Monday 16 March 
Ceres PowerHalf Year Results
Old MutualFull Year Results
DialightFull Year Results
SThreeTrading Statement
Volution GroupHalf Year Results
Telit CommunicationsFull Year Results
Tuesday 17 March 
Litigation CapitalHalf Year Results
Gamma CommuncationsFull Year Results
ContourGlobalFull Year Results
Smart Metering SystemsFull Year Results
Harworth GroupFull Year Results
Tritax Big BoxFull Year Results
Good EnergyFull Year Results
Gamesys Full Year Results
Baillie Gifford Shin NipponFull Year Results
ScS GroupHalf Year Results
PolypipeFull Year Results
AntofagastaFull Year Results
SoftcatHalf Year Results
e-therapeuticsFull Year Results
TI Fluid SystemsFull Year Results
VecturaFull Year Results
FergusonHalf Year Results
Wednesday 18 March 
WM Morrison SupermarketsFull Year Results
MJ HudsonHalf Year Results
Judges ScientificFull Year Results
Centaur MediaFull Year Results
PendragonFull Year Results
Empiric Student PropertyFull Year Results
Strix GroupFull Year Results
EmpresariaFull Year Results
Cello HealthFull Year Results
Accesso TechnolgyFull Year Results
FerrexpoFull Year Results
EMIS GroupFull Year Results
Tribal GroupFull Year Results
S4 CapitalFull Year Results
RestoreFull Year Results
Thursday 19 March 
NextFull Year Results
Ocado GroupQ1 Results
Halmatrading Statement
Sanne GroupFull Year Results
SafestyleUKFull Year Results
Portmeirion GroupFull Year Results
Capital DrillingFull Year Results
Everyman Media GroupFull Year Results
LoopUp Full Year Results
Genel EnergyFull Year Results
TclarkeFull Year Results
Hurricane EnergyFull Year Results
IG GroupQ3 Results
FW ThorpeFull Year Results
SportechFull Year Results
Energean Oil & GasFull Year Results
Gym GroupFull Year Results
Onesavings BankFull Year Results
Friday 20 March 
Caledonia Full Year Results
InvestecTrading Statement
Faron PharmaceuticalsFull Year Results
Manchester & London Investment TrustHalf Year Results
JD WetherspoonHalf Year Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
9 Mar 2020 10:26

Faron gets FDA tick from proposed design of next 'Traumakine' study

(Sharecast News) - Faron Pharmaceuticals announced on Monday that the US Food and Drug Administration (FDA) has accepted its proposed protocol design for the next 'Traumakine' study in acute respiratory distress syndrome (ARDS) patients, following its protocol submission in February.

Read more
5 Mar 2020 14:28

Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings

Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings

Read more
2 Mar 2020 12:04

Faron Pharmaceuticals Buys Rights For AOC3 Antagonist Platform

Faron Pharmaceuticals Buys Rights For AOC3 Antagonist Platform

Read more
2 Mar 2020 10:08

Faron Pharmaceuticals acquires rights to AOC3 inhibitors

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has acquired rights for the potential new use of AOC3 inhibitors covered by a recently filed patent application.

Read more
6 Feb 2020 14:17

Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback

Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback

Read more
27 Jan 2020 11:22

Faron Pharma To Test Clevegen In Patients With Ovarian Cancer

Faron Pharma To Test Clevegen In Patients With Ovarian Cancer

Read more
13 Jan 2020 11:54

Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug

Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug

Read more
30 Dec 2019 15:39

Faron Pharma requests arbitration over Traumakine manufacturing deal

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Monday that, further to the update on 'Traumakine' drug substance manufacturing on 2 October, it has carried out a detailed investigation into the circumstances around manufacturing arrangements.

Read more
30 Dec 2019 10:56

Faron Pharma Files For Arbitration Amid Traumakine Deal Termination

Faron Pharma Files For Arbitration Amid Traumakine Deal Termination

Read more
11 Dec 2019 13:42

Faron Pharmaceuticals upbeat on new data from 'MATINS' study

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced new data from 'MATINS'-trial patients on Wednesday, to be presented at the ESMO Immuno-Oncology Congress 2019 in Geneva.

Read more
11 Dec 2019 10:45

Faron Pharmaceuticals Pleased With Clevegen Clinical Trial Performance

Faron Pharmaceuticals Pleased With Clevegen Clinical Trial Performance

Read more
29 Nov 2019 10:23

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital

Read more
28 Nov 2019 11:56

Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status

Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status

Read more
21 Nov 2019 12:56

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing

Read more
8 Nov 2019 10:30

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.